Vitamin D metabolites (25‐hydroxyvitamin D, 24,25‐dihydroxyvitamin D and 1,25‐dihydroxyvitamin D) and osteocalcin in β‐thalassaemia
- 1 June 1997
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 86 (6) , 594-599
- https://doi.org/10.1111/j.1651-2227.1997.tb08940.x
Abstract
Serum levels of the vitamin D metabolites 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D. and of osteocalcin. C-tenninal parathyroid hormone and other biochemical indices related to bone metabolism, were determined in two groups of patients with β-thalassaemia aged 5–10 years (summer 7.8 ± 0.4 years, mean ± SEM. and winter 7.7 ± 0.4 years, group A, n= 15) and 11–23 years (16.6 ± 0.9 and 15.7 ± 0.9 years in summer and winter, respectively, group B, n= 22). Emphasis was given to populations of school and adolescent ages and to the seasons of summer and winter when vitamin D status demonstrates the widest extremes. The mean serum levels of 25-hydroxyvitamin D in patients aged 5–10 years did not differ from those of controls during both seasons studied. In contrast, in the age group 11–23 years these levels were found to be lower in patients than in controls both in winter (10.6 ± 0.9ng/ml vs 15.0 ± 2.0ng/ml, p < 0.05) and summer (20.2 ± 2.1 ng/ml vs 27.1 ± 2.0ng/ml, p < 0.05). The serum concentrations of 24,25-dihydroxyvitamin D were lower in the thalassaemic patients than in controls in both age groups and both seasons. In the patients under 10 years of age the mean values of this metabolite in winter were 1.06 ± 0.17 ng/ml vs 1.68 ± 0.20 ng/ml in the respective controls (p < 0.05), and in summer 1.44 ± 0.11 ng/ml vs 2.35 ± 0.36 ng/ml in controls (p < 0.05). In the group of patients aged 11–23 years, the mean levels of 24,25-dihydroxyvitamin D were in winter 0.65 ± 0.12 ng/ml vs 1.12 ± 0.19 ng/ml (p < 0.05) in controls and in summer 1.34 ± 0.12 ng/ml vs 1.84 ± 0.20 ng/ml (p < 0.05). The 1,25-dihydroxyvitamin D concentrations in both thalassaemic patient groups were significantly no different from those in the respective control groups. Serum osteocalcin, C-terminal parathyroid hormone, calcium, inorganic phosphate and alkaline phosphatase levels in the patients studied were not significantly different from those in controls, except for calcium and phosphate in the older group. In the older group of thalassaemic patients, serum calcium was lower than in the controls (2.26 ± 0.03 vs 2.37 ± 0.03 mmol/1, p < 0.05) in summer and serum phosphate higher than in the controls in winter (1.47 ± 0.05 mmol/1 vs 1.27 ± 0.06 mmol/1. p < 0.05).Keywords
This publication has 19 references indexed in Scilit:
- Bone disease in children with homozygous β-thalassemiaBone and Mineral, 1990
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone γ-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient ratsCalcified Tissue International, 1987
- Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major.Archives of Disease in Childhood, 1987
- Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia majorEuropean Journal of Pediatrics, 1986
- VITAMIN D: RECENT ADVANCESAnnual Review of Biochemistry, 1983
- Relation between Erythropoiesis and Bone Metabolism in ThalassemiaNew England Journal of Medicine, 1981
- Serum 25-hydroxyvitamin D levels in thalassaemia.Archives of Disease in Childhood, 1978
- COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1Journal of Clinical Endocrinology & Metabolism, 1971
- ANEMIA IN CHILDRENAmerican Journal of Diseases of Children, 1927